Skip to main content
Fig. 1 | BMC Gastroenterology

Fig. 1

From: Long-term survival of a patient with microsatellite-stable refractory colorectal cancer with regorafenib and PD-1 inhibitor sintilimab: a case report and review of literature

Fig. 1

CT: pelvic cavity to assess disease status and progression. CT image of pelvic cavity to assess disease status before starting treatment with regorafenib and sintilimab (a Arrows indicate metastatic focus before treatment). CT image of pelvic cavity to assess disease progression with regorafenib and sintilimab treatment before treatment (b–d Arrows indicate metastatic focus shows that the tumor size has decreased during treatment duration)

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us